Description
What is Lipo C w/ B Vitamins?
Lipo C is the classical three‑component lipotropic blend (Methionine + Inositol + Choline, “MIC”) supplemented with B‑complex vitamins. The “C” in Lipo C typically refers to the combination of methylation cofactors (choline being the downstream lipid‑export‑relevant component) rather than to ascorbic acid. Like MICC, it is a staple of aesthetic/weight‑loss clinic research protocols.
Typical Constituents & Mechanism
- Methionine: sulfur amino acid, methyl donor via SAM, phosphatidylcholine synthesis
- Inositol: second‑messenger precursor in insulin/PI3K signaling
- Choline: phosphatidylcholine and acetylcholine precursor; required for hepatic VLDL export
- B-complex vitamins: cofactors for one‑carbon metabolism and energy pathways; commonly B1 (thiamine), B2, B3, B5, B6, B12
Preparation Details
- Volume: 10 mL multi‑dose vial
- Form: Liquid preparation
- Composition: Please refer to lot‑specific Certificate of Analysis for exact ingredient list and concentrations
Research‑Reference Context
As with the MICC class, individual constituents have substantial independent literature (Zeisel on choline; Unfer on inositol). However, rigorous RCT evidence that Lipo C / MIC injections accelerate fat loss beyond diet/exercise is limited. B‑complex injections are well established for nutrient deficiency correction.
Known Side Effects Reported in Clinical Literature
- Injection‑site pain, erythema, bruising
- Sulfurous body odor/taste (methionine metabolism)
- Transient nausea, flushing, mild GI upset
- Rare hypersensitivity reactions (particularly to preservatives)
- Contraindicated in severe hepatic or renal impairment per standard practice
Storage & Handling
- Lyophilized (unreconstituted) vials: store at −20°C long‑term; short‑term 2–8°C acceptable.
- After reconstitution with bacteriostatic or sterile water: store at 2–8°C; use within 14–28 days per standard peptide stability guidance.
- Protect from light, heat, and repeated freeze‑thaw cycles. Handle in a sterile laboratory environment.
Certificate of Analysis
A Certificate of Analysis (COA) confirming identity and purity by HPLC / MS is available upon request. Contact Lonestar Peptides for lot‑specific documentation.
Summaries reference peer‑reviewed preclinical and clinical literature available as of early 2025. Newer findings may not be reflected. Researchers should consult current literature and conduct their own due diligence. Lonestar Peptides makes no claim of therapeutic benefit.
